Cannabis, CBD, and Public Health Breakfast and Town Hall Meeting

 

Sunday, November 3, 2019 8:00 am – 11:00 am

Pennsylvania Convention Center | Room 116

Part of the pre-conference programming for the APHA Annual Conference & Expo (separate registration fee applies; registration for the APHA conference is encouraged, but not required).

Fees: $20

Student — $5

2019 PPSI Supporters — Free

Online registration will close at 12:00am CDT on October 31.
On site registration will be available beginning at 7:30am EST on November 3.

Register Today!
Cannabis CBD, and Public Health

 

Visit us at the APHA Annual Conference & Expo — Booth 1312 in the Expo Hall

Why Attend?

  • Recreational marijuana use is legal in 10 US states, while medicinal marijuana is legal in 33
  • CBD oils and CBD-containing products are appearing in specialty shops, pharmacies, and medical marijuana dispensaries.
  • Recent polls reveal that 55 million Americans currently use marijuana and one in every seven adults uses CBD products.
  • There is an increased possibility that members of the general public will be consuming cannabis or CBD along with prescription or over-the-counter medications.
  • As evidenced by the May 31, 2019 FDA public hearing, many other questions exist surrounding CBD safety in regard to consumption levels, consuming multiple products simultaneously, pregnancy and child exposure to CBD products, and prolonged usage of CBD.

This program is presented through a grant from Greenwich Bioscience.

Who should attend:

  • Healthcare Professionals who have patients using medical or recreational marijuana, especially who practice in states with legalized or decriminalized recreational marijuana
  • Healthcare Professionals who have added or are considering adding CBD products to their practice
  • Healthcare Professionals with patients using OTC products containing CBD purchased elsewhere
  • Healthcare Professionals who work in dispensaries

PROGRAM

Welcome & Introductions

Susan Bartlemay, RPh, FACA, FAPhA, Executive Vice-President, American College of Apothecaries

Beyond the Buzz: Legal and Regulatory Issues Relating to CBD

Alice Mead, JD, LLM, Vice President of US Public Policy, Greenwich Biosciences

CBD: Clinical Data and Quality Considerations

Kathryn Nichol, PhD Senior Director, Medical Affairs, Greenwich Biosciences

Cannabis and Your Patient: The Good, The Bad, and The Ugly

Thomas C. Kupiec, PhD, ARL Bio Pharma

Making Sense of the Cannabis Chaos

Daniel A. Hussar, PhD, Dean Emeritus and Remington Professor Emeritus of the Philadelphia College of Pharmacy, University of the Sciences

Organizing a CBD Education and Awareness Campaign

Fred Mayer, RPh, MPH, FACA, Chairman, PPSI

Register Today!